EE+ POEM Archive
Benefit of low-dose aspirin for type 2 diabetes is uncertain
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Benefit of Low-dose Aspirin for Type 2 Diabetes Is Uncertain." EE+ POEM Archive, John Wiley & Sons, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/426655/all/Benefit_of_low_dose_aspirin_for_type_2_diabetes_is_uncertain.
Benefit of low-dose aspirin for type 2 diabetes is uncertain. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2024. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426655/all/Benefit_of_low_dose_aspirin_for_type_2_diabetes_is_uncertain. Accessed December 6, 2024.
Benefit of low-dose aspirin for type 2 diabetes is uncertain. (2024). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426655/all/Benefit_of_low_dose_aspirin_for_type_2_diabetes_is_uncertain
Benefit of Low-dose Aspirin for Type 2 Diabetes Is Uncertain [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426655/all/Benefit_of_low_dose_aspirin_for_type_2_diabetes_is_uncertain.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Benefit of low-dose aspirin for type 2 diabetes is uncertain
ID - 426655
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426655/all/Benefit_of_low_dose_aspirin_for_type_2_diabetes_is_uncertain
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
